Health
Australian-led study provides another effective treatment for COVID-19 – The Australian Financial Review
International research, led by Australia, has opened up a whole class of anti-inflammatory drugs for the treatment of COVID-19.
The effectiveness of dexamethasone was first reported by the UKs national RECOVERY trial and published in the New England Journal of Medicine in July.
It reduced the risk of death in those critically ill, by 20 to 30 per cent. Now, it has been shown hydrocortisone does the same and is an effective alternative.
There was global concern about the surge in demand for dexamethasone, and this will help to relieve the pressure, said Professor Webb, who is an intensive care clinician.
He said the re…
-
General22 hours agoCanberra man accused of flashing and assaulting 12-year-old girl released on bail
-
Noosa News23 hours agoQueensland plan to increase lethal shark control measures goes against advice of government-commissioned report
-
Business23 hours agoHow Australia’s most valuable company is using AI to compete
-
Noosa News23 hours agoDrought pushes farmers’ mental health to the brink across southern Australia